Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection

Aim: Identifying the genetic expression profile of CD133+ cells from HCC patients compared to CD133+ cells from healthy volunteers that may contribute in hepatocarcinogenesis process. Method: Circulating CD133+ cells were sorted from the peripheral blood of HCC patients as well as from healthy volun...

Full description

Bibliographic Details
Main Authors: Abdel-Rahman N. Zekri, Enas R. El-Sisi, Zeinab F. Abdallah, Alaa Ismail, Ahmed Barakat Barakat
Format: Article
Language:English
Published: SpringerOpen 2017-03-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110036216300772
_version_ 1819042884833247232
author Abdel-Rahman N. Zekri
Enas R. El-Sisi
Zeinab F. Abdallah
Alaa Ismail
Ahmed Barakat Barakat
author_facet Abdel-Rahman N. Zekri
Enas R. El-Sisi
Zeinab F. Abdallah
Alaa Ismail
Ahmed Barakat Barakat
author_sort Abdel-Rahman N. Zekri
collection DOAJ
description Aim: Identifying the genetic expression profile of CD133+ cells from HCC patients compared to CD133+ cells from healthy volunteers that may contribute in hepatocarcinogenesis process. Method: Circulating CD133+ cells were sorted from the peripheral blood of HCC patients as well as from healthy volunteers using magnetic activated cell sorting. The differential expression profile of stem cell related genes was performed using the Stem Cell PCR profiling assay. Results: Data analysis of stem cells related genes in CD133+ cells of the HCC group compared to the control group showed that; CCND2, COL1A1, CTNNA1, DLL3, JAG1, KRT15, MYC, NOTCH2, T and TERT were up-regulated (fold change = 80, 68.6, 6.67, 7.22, 3.8, 15.2, 14.5, 105.6, 26.6 and 99 respectively while only CD3D was down-regulated (fold change = 0.055) in HCC patients. However, after application of Beferroni correction to adjust P-value; KRT15 was the only gene that was significantly over expressed in CD133+ cells of HCC compared to control group (P-value = 0.012). Conclusion: KRT15 can be used to differentiate between circulating CD133+ cells from HCC group and control group. However, further study may be needed to confirm on the protein level.
first_indexed 2024-12-21T09:47:59Z
format Article
id doaj.art-7e980f3ef0184e40920a9181f95fca1a
institution Directory Open Access Journal
issn 1110-0362
language English
last_indexed 2024-12-21T09:47:59Z
publishDate 2017-03-01
publisher SpringerOpen
record_format Article
series Journal of the Egyptian National Cancer Institute
spelling doaj.art-7e980f3ef0184e40920a9181f95fca1a2022-12-21T19:08:16ZengSpringerOpenJournal of the Egyptian National Cancer Institute1110-03622017-03-01291192410.1016/j.jnci.2016.12.002Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infectionAbdel-Rahman N. Zekri0Enas R. El-Sisi1Zeinab F. Abdallah2Alaa Ismail3Ahmed Barakat Barakat4Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, EgyptMolecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, EgyptMolecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, EgyptSurgery Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptMicrobiology Department, Faculty of Science, Ain Shams University, Cairo, EgyptAim: Identifying the genetic expression profile of CD133+ cells from HCC patients compared to CD133+ cells from healthy volunteers that may contribute in hepatocarcinogenesis process. Method: Circulating CD133+ cells were sorted from the peripheral blood of HCC patients as well as from healthy volunteers using magnetic activated cell sorting. The differential expression profile of stem cell related genes was performed using the Stem Cell PCR profiling assay. Results: Data analysis of stem cells related genes in CD133+ cells of the HCC group compared to the control group showed that; CCND2, COL1A1, CTNNA1, DLL3, JAG1, KRT15, MYC, NOTCH2, T and TERT were up-regulated (fold change = 80, 68.6, 6.67, 7.22, 3.8, 15.2, 14.5, 105.6, 26.6 and 99 respectively while only CD3D was down-regulated (fold change = 0.055) in HCC patients. However, after application of Beferroni correction to adjust P-value; KRT15 was the only gene that was significantly over expressed in CD133+ cells of HCC compared to control group (P-value = 0.012). Conclusion: KRT15 can be used to differentiate between circulating CD133+ cells from HCC group and control group. However, further study may be needed to confirm on the protein level.http://www.sciencedirect.com/science/article/pii/S1110036216300772Hepatocellular carcinomaCD133+ cellsHCV
spellingShingle Abdel-Rahman N. Zekri
Enas R. El-Sisi
Zeinab F. Abdallah
Alaa Ismail
Ahmed Barakat Barakat
Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
Journal of the Egyptian National Cancer Institute
Hepatocellular carcinoma
CD133+ cells
HCV
title Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
title_full Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
title_fullStr Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
title_full_unstemmed Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
title_short Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
title_sort gene expression profiling of circulating cd133 cells of hepatocellular carcinoma patients associated with hcv infection
topic Hepatocellular carcinoma
CD133+ cells
HCV
url http://www.sciencedirect.com/science/article/pii/S1110036216300772
work_keys_str_mv AT abdelrahmannzekri geneexpressionprofilingofcirculatingcd133cellsofhepatocellularcarcinomapatientsassociatedwithhcvinfection
AT enasrelsisi geneexpressionprofilingofcirculatingcd133cellsofhepatocellularcarcinomapatientsassociatedwithhcvinfection
AT zeinabfabdallah geneexpressionprofilingofcirculatingcd133cellsofhepatocellularcarcinomapatientsassociatedwithhcvinfection
AT alaaismail geneexpressionprofilingofcirculatingcd133cellsofhepatocellularcarcinomapatientsassociatedwithhcvinfection
AT ahmedbarakatbarakat geneexpressionprofilingofcirculatingcd133cellsofhepatocellularcarcinomapatientsassociatedwithhcvinfection